Intra-abdominal infections (IAIs) are common surgical emergencies and have been reported
as major contributors to non-trauma deaths in hospitals worldwide. The cornerstones of …

Antibacterial fluoroquinolones (FQs) are frequently used in treating infections. However, the
value of FQs is debatable due to their association with severe adverse effects (AEs). The …

Antibiotics are recognized widely for their benefits when used appropriately. However, they
are often used inappropriately despite the importance of responsible use within good clinical …

Intra-abdominal infections (IAIs) are common surgical emergencies and have been reported
as major contributors to non-trauma deaths in the emergency departments worldwide. The …

Obstruction and perforation due to colorectal cancer represent challenging matters in terms
of diagnosis, life-saving strategies, obstruction resolution and oncologic challenge. The aims …

Ceftazidime-avibactam (Zavicefta®) is an intravenously administered combination of the
third-generation cephalosporin ceftazidime and the novel, non-β-lactam β-lactamase …

Background Peptic ulcer disease is common with a lifetime prevalence in the general
population of 5–10% and an incidence of 0.1–0.3% per year. Despite a sharp reduction in …

Intra-abdominal infections (IAI) are among the most common global healthcare challenges
and they are usually precipitated by disruption to the gastrointestinal (GI) tract. Their …

This paper reports on the consensus conference on the management of intra-abdominal
infections (IAIs) which was held on July 23, 2016, in Dublin, Ireland, as a part of the annual …

Background Traditionally, renal function in critically ill patients has been assessed to identify
renal dysfunction, and dose adjustment is generally accepted in such a context …